1.2.30 Participation in clinical studies Estimated reading: 1 minute 1733 views 1 Aim and purpose Participation in clinical trials should be regulated in accordance with the Declaration of Helsinki with regard to the specifics of information, consent and refusal of participation. Randomisation, placebo administration and additional examination dates must be regulated. 2 Scope of application 3 Description 4 Documentation 5 Resources 5.1 Time required 6 Risks 7 Responsibilities, qualification 8 Notes and comments 9 Applicable documents 9.1 Literature, regulations 9.2 Terms Attachments 1.2.30 Participation in clinical trials - Previous 1.2.29 Establishment of an ethics consultation and ethical case discussion Next - 1.2.30 Participation in clinical trials 1.2.31 Organ and tissue donation
